Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of MDPK67b in Healthy Volunteers
NCT04839120Phase 1Completed
- Sponsor
- Med Discovery SA
- Start
- Feb 2017
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prostatic neoplasms comparing MDPK67b with Placebo (2 arms). Primary endpoints: Incidence of Adverse Events at Week 8 and MDPK67b serum level up to 144 hours. Started Feb 2017; status: completed.
02
Drugs
MDPK67b
03
Conditions
prostatic neoplasms
Beyond the preview
Go deeper on NCT04839120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839120.